Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001549595-25-000103

Chief Financial Officer sold 5,402 shares at $11.03 ($59,598)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

van Houte Hans · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-08-01 Sale : show line 1 in the form 10b5-1 −5,402 $11.03 $59,598 35,512 D
Open-market sales · 5,402 sh · avg $11.03 · $59,598
Loading xslF345X05/wk-form4_1754082538.xml…